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ABSTRACT 
 
The evolution of drug resistant bacteria has now becoming a major concern in the search for new 
antibacterial agent. Ongoing interest has also developing to find a new class of compounds with antioxidant 
properties. Herein, a series of hydroxylated chalcones 1a-g and aspirin-chalcone derivatives 2a-g were 
successfully synthesised for antibacterial and antioxidant properties. Chalcones 1a-g were prepared by 
Claisen-Schmidt condensation of 4-hydroxyacetophenone and benzaldehyde derivatives, while 2a-g were 
synthesised via esterification of aspirin with 1a-g. All the synthesised compounds were elucidated using 
CHNS elemental analysis, FTIR, 1H and 13C NMR spectroscopy, and X-ray crystallography. All compounds 
were evaluated for antibacterial assay via disc diffusion method and antioxidant assay using stable free radical 
2,2-diphenyl-1-picrylhydrazyl (DPPH). Only 1a showed moderate activity against Escherichia coli, while 1b-g 
and 2a-g showed no inhibition against E. coli and Staphylococcus aureus in comparison ampicillin as standard 
antibiotic. Compounds 1b-g and 2a-g having various substituents contributed to bulky molecular structures 
and caused difficult penetration into the cell membrane thus, unable to inhibit the bacterial growth. 
Compounds 1a-g and 2a-g also displayed poor antioxidant properties on DPPH in comparison to ascorbic 
acid due to low phenolic pharmacophore. The formation of bulky structures for 2a-g have hindered the 
antioxidant properties compared to 1a-g. 
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INTRODUCTION 
 
Aspirin is a well-known non-steroidal anti-inflammatory drug that has been used as medication to treat fever 
and inflammation for over the century (Vane & Botting, 2003). It has been chemically modified from salicylic 
acid, an active metabolite which is extracted from bark of Willow tree (Nordin et al., 2018). Prolonged use of 
aspirin however, can cause adverse effects such as vomiting and stomach bleeding (Vane & Botting, 2003). 
Structural modification of aspirin has improved its efficacy with less gastrointestinal toxicity compared to 
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standard aspirin (Huang et al., 2014). Modification of aspirin by adding various functional groups has displayed 
wide range of biological properties such as antibacterial, antifungal and anti-inflammatory activities (Nordin et 
al., 2018).  
 
Chalcone is a compound belongs to flavonoid family and commonly found in fruits, vegetables and other plant 
products (Panche et al., 2016). Chalcone consists of two phenyl rings and connected by three carbon bridges 
containing α,β-unsaturated ketone which is claimed to contribute to the activity of chalcone (Al-Rawi et al., 
2018). Various substituents was introduced to its molecular structure such as hydroxyl, methoxy or halogen 
groups which reported for antibacterial, antioxidant, antifungal and many others (Hasan et al., 2015; Kumbhar 
et al., 2014; Lahsasni et al., 2014). Studies on the properties of chalcones and their biological activities become 
an interest among researchers, mainly due to its simplicity in synthesis and the versatility of the chalcone 
structure for chemical modification (Zhuang et al., 2017). 
 
Throughout these years, various bacterial-causing diseases were reported (Rubin & Reisner, 2014). 
Consequently, antibacterial drugs were manufactured and used to treat these diseases (Gulkok et al., 2012). 
Improper usage of these drugs however, caused the bacteria to evolve into drug resistant bacteria which reduce 
the effectiveness of the drugs (Richard-Kortum, 2010). The continuing improvement of new antimicrobial 
agents is therefore remains a priority (Gulkok et al., 2012). 
 
Apart from bacterial infection, free radical is a reactive intermediate containing unpaired electron which could 
also cause various diseases (Singhal et al., 2011) and could give adverse effect on lipids, proteins and DNA in 
human body (Mohana & Kumar, 2013). Antioxidant drug is commonly used to prevent the damages by free 
radical and inhibit the reactivity (Belsare et al., 2010). Thus, antioxidant drugs were developed to reduce the 
implications of free radicals (Mohana & Kumar, 2013). 
 
In this paper, hydroxylated chalcones bearing substituents such as methoxy, bromine and chlorine were 
prepared and incorporated onto aspirin in order to enhance the antibacterial and antioxidant properties 
possessed by both precursor compounds starting from readily available aspirin. The resulting compound is 
envisaged to possess greater potential of biological activities. All the synthesized compounds were evaluated 
against E. coli and S. aureus, and also free radical scavenging activity on 2,2-diphenyl-1-picrylhydrazyl (DPPH). 
 
 
MATERIALS AND METHODS 
 
Chemical and reagents 
 
4-hydroxyacetophenone, methoxy/chloro/bromobenzaldehyde, potassium hydroxide (KOH), N,N-dimethyl-
4-aminopyridine (DMAP) and oxalyl chloride were purchased from Merck. Aspirin and N,N-
dicyclohexylcarbodiimide (DCC) were obtained from Acros Organics. Magnesium sulphate (MgSO4) anhydrous 
and triethylamine were purchased from J.T. Baker. All other reagents and solvents were used as received without 
further purification. 
 
Measurements 
 
Melting points of all synthesized compounds were determined on Stuart SMP3 using open tube capillary method 
and are uncorrected. All compounds were characterised using CHNS Vario MICRO Elementar 
Analysensysteme GmbH. FTIR spectra were recorded as KBr pellets on Perkin Elmer 1605 FTIR 
Spectrophotometer. 1H-NMR and 13C-NMR spectra were recorded on JEOL ECA 500 at 500MHz (1H) and 
125MHz (13C) with the chemical shift reported relative to DMSO-d6 as the standard reference and chemical 
shift values (δ) were expressed in parts per million (ppm). Single crystal X-ray was collected on Bruker APEXII 
DUO CCD area-detector diffractometer. 
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General Procedure for the Preparation of Hydroxylated Chalcones 1a-g 
 
Hydroxylated chalcones 1a-g were synthesised via similar method reported by Ngaini et al., (2013) utilising 4-
hydroxyacetophenone) and benzaldehyde derivatives.  
 
(E)-1-(4-hydroxyphenyl)-3-phenylprop-2-en-1-one (1a): Compound 1a was obtained as yellow solid. Yield: 
1.04 g (46%),  m.p.: 177-178 °C, vmax (KBr/cm-1) 3136 (O-H), 1646 (C=O), 1606 (Ar-C), 980 (C=CH). δH (500 
MHz, DMSO-d6) 6.90 (2H, d, J=9.2 Hz, Ar-H), 7.42-7.45 (2H, m, Ar-H), 7.67 (1H, d, J=15.3 Hz, C=CH), 7.85-
7.86 (3H, m, Ar-H), 7.88 (1H, d, J=16.1 Hz, C=CH), 8.07 (2H, d, J=8.4 Hz, Ar-H). δC (125 MHz, DMSO-d6) 
115.4 (Ar-C), 122.1 (C=C), 128.7 (Ar-C), 128.9 (Ar-C), 129.1 (Ar-C), 130.3 (Ar-C), 131.2 (Ar-C), 134.9 (Ar-C), 
142.8 (C=C), 162.2 (Ar-C), 187.2 (C=O). 
 
(E)-1-(4-hydroxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one (1b): Compound 1b was obtained as 
yellow solid. Yield: 1.10 g (43%), m.p.: 165-166 °C, vmax (KBr/cm-1) 3302 (O-H), 2828 (OCH3), 1653 (C=O), 
1580 (Ar-C), 974 (C=CH). δH (500 MHz, DMSO-d6) 3.83 (3H, s, OCH3), 6.90 (2H, d, J=5.2 Hz, Ar-H), 7.00 
(1H, d, J=8.6 Hz, Ar-H), 7.33 (1H, t, J=8.6 Hz, Ar-H), 7.40 (1H, d, J=9.7 Hz, Ar-H), 7.46 (1H, s, Ar-H), 7.64 
(1H, d, J=14.3 Hz, C=CH), 7.90 (1H, d, J=12.1 Hz, C=CH), 8.07 (2H, d, J=8.0 Hz, Ar-H). δC (125 MHz, 
DMSO-d6) 55.8 (OCH3), 111.7 (Ar-C), 116.0 (Ar-C), 116.9 (Ar-C), 122.0 (Ar-C), 122.9 (C=C), 129.9 (Ar-C), 
130.4 (Ar-C), 131.8 (Ar-C), 136.8 (Ar-C), 143.2 (C=C), 160.2 (Ar-C), 162.8 (Ar-C), 187.7 (C=O).  
 
(E)-1-(4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one (1c): Compound 1c was obtained as yellow 
solid. Yield: 2.42 g (95%), m.p.: 154-155 °C, vmax (KBr/cm-1) 3383 (O-H), 2833 (OCH3), 1642 (C=O), 1601 (Ar-
C), 1036 (C=CH). δH (500 MHz, DMSO-d6) 3.81 (3H, s, OCH3), 6.89 (2H, d, J=8.4 Hz, Ar-H), 6.99 (2H, d, 
J=8.4 Hz, Ar-H), 7.64 (1H, d, J=15.3 Hz, C=CH), 7.75 (1H, d, J=14.5 Hz, C=CH), 7.80 (2H, d, J=10.7 Hz, Ar-
H), 8.05 (2H, d, J=12.3 Hz, Ar-H). δC (125 MHz, DMSO-d6) 55.9 (OCH3), 114.9 (Ar-C), 115.9 (Ar-C), 120.1 
(C=C), 128.0 (Ar-C), 129.9 (Ar-C), 131.1 (Ar-C), 131.6 (Ar-C), 143.2 (C=C), 161.6 (Ar-C), 162.6 (Ar-C), 187.6 
(C=O). 
 
(E)-3-(2,5-dimethoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one (1d): Compound 1d was obtained as 
yellow crystal. Yield: 1.59 g (56%), m.p.: 167-168 °C, vmax (KBr/cm-1) 3166 (O-H), 2957 (OCH3), 1643 (C=O), 
1591 (Ar-C), 989 (C=CH). δH (500 MHz, DMSO-d6) 3.82 (3H, s, OCH3), 3.88 (3H, s, OCH3), 6.59-6.62 (2H, 
m, Ar-H), 6.88 (2H, d, J=9.2 Hz, Ar-H), 7.69 (1H, d, J=16.0 Hz, Ar-H), 7.85 (1H, d, J=8.6 Hz, C=CH), 7.91 
(1H, d, J=16.1 Hz, C=CH), 7.99 (2H, d, J=9.2 Hz, Ar-H). δC (125 MHz, DMSO-d6) 56.2(OCH3), 56.7 (OCH3), 
113.0 (Ar-C), 113.5 (Ar-C), 115.9 (Ar-C), 118.3 (Ar-C), 122.6 (C=C), 124.2 (Ar-C), 129.7 (Ar-C), 131.7 (Ar-C), 
137.6 (C=C), 153.1 (Ar-C), 153.8 (Ar-C), 162.7 (Ar-C), 187.8 (C=O). 
 
(E)-3-(3,5-dimethoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one (1e): Compound 1e was obtained as 
yellow solid. Yield: 1.31 g (60%), m.p.: 133-134 °C, vmax (KBr/cm-1) 3186 (O-H), 2841 (OCH3), 1651 (C=O), 
1596 (Ar-C), 974 (C=CH). δH (500 MHz, DMSO-d6) 3.80 (6H, s, OCH3), 6.56 (1H, s, Ar-H), 6.90 (2H, d, J=8.4 
Hz, Ar-H), 7.05 (2H, s, Ar-H), 7.59 (1H, d, J=15.3 Hz, C=CH), 7.90 (1H, d, J=15.3 Hz, C=CH), 8.08 (2H, d, 
J=9.2 Hz, Ar-H). δC (125 MHz, DMSO-d6) 55.5 (OCH3), 102.6 (Ar-C), 106.6 (Ar-C), 115.4 (Ar-C), 122.6 (C=C), 
129.1 (Ar-C), 131.3 (Ar-C), 136.9 (Ar-C), 142.9 (C=C), 160.7 (Ar-C), (Ar-C), 162.3 (Ar-C), 187.2 (C=O). 
 
(E)-3-(4-bromophenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one (1f): Compound 1f was obtained as yellow 
solid. Yield: 0.73 g (24%), m.p.: 207-208 °C, vmax (KBr/  cm-1) 3096 (O-H), 1643 (C=O), 1543 (Ar-C), 980 
(C=CH). δH (500 MHz, DMSO-d6) 6.90 (2H, d, J=8.6 Hz, Ar-H), 7.63-7.66 (3H, m, Ar-H & C=CH), 7.81 (2H, 
d, J=8.6 Hz, Ar-H), 7.93 (1H, d, J=15.5 Hz, C=CH), 8.07 (2H, d, J=8.6 Hz, Ar-H). δC (125 MHz, DMSO-d6) 
115.4 (Ar-C), 122.9 (C=C), 123.6 (Ar-C), 129.0 (Ar-C), 130.6 (Ar-C), 131.2 (Ar-C), 131.8 (Ar-C), 134.2 (Ar-C), 
141.3 (C=C), 162.3 (Ar-C), 187.0 (C=O). 
 
(E)-3-(4-chlorophenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one (1g): Compound 1g was obtained as yellow 
solid. Yield: 1.45 g (56%), m.p.: 228-229 °C, vmax (KBr/cm-1) 3095 (O-H), 1643 (C=O), 1537 (Ar-C), 981 
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(C=CH). δH (500 MHz, DMSO-d6) 6.90 (2H, d, J=8.6 Hz, Ar-H), 7.49 (2H, d, J=8.6 Hz, Ar-H), 7.65 (1H, d, 
J=15.5 Hz, C=CH), 7.90-7.94 (3H, m, Ar-H & C=CH), 8.07 (2H, d, J=9.2 Hz, Ar-H). δC (125 MHz, DMSO-
d6) 115.4 (Ar-C), 122.9 (C=C), 128.8 (Ar-C), 129.0 (Ar-C), 130.3 (Ar-C), 131.2 (Ar-C), 133.8 (Ar-C), 134.7 (Ar-
C), 141.2 (C=C), 162.2 (Ar-C), 187.0 (C=O). 
 
General Procedure for the Preparation of Aspirin-Chalcones Derivatives 2a-g 
 
Method 1 
 
Aspirin-chalcones derivatives 2a-g were synthesised using similar method reported by Ngaini et al., (2013) with 
several modifications. The resulting mixture was filtered and extracted using distilled water (2 x 25 mL). The 
organic layer was dried over MgSO4 anhydrous and solvent was removed under reduced pressure to form yellow 
precipitate. The product formed was recrystallized from ethanol to afford 2a-g. 
 
Method 2 
 
Aspirin (2 mmol) in 10 mL dry DCM was added to a stirred solution of 1a-g (2 mmol) in 10 mL dry DCM. 
DCC (2 mmol) and DMAP (1 mmol) in 5 mL dry DCM respectively, were added into the mixture and stirred 
for 5 min at 0 °C. The white precipitate (dicyclohexylurea) formed was filtered off from the reaction. The filtrate 
was allowed to be stirred at room temperature for 5 h and evaporated under vacuum to form yellow precipitate. 
The precipitate formed was purified by column chromatography (silica gel, 1:4 ethyl acetate/hexane) to afford 
2a-g (Ho et al., 2017). 
 
(E)-4-cinnamoylphenyl 2-acetoxybenzoate (2a): Compound 2a was obtained as white solid. Yield: 0.26 g, 
(67%), m.p.: 210-211 °C, (Found: C, 74.39; H, 4.89. C24H18O5 Requires C, 74.60; H, 4.70%); vmax (KBr/cm-1) 
1766 (C=O ester), 1662 (C=O), 1605 (Ar-C), 1056 (C=CH). δH (500 MHz, DMSO-d6) 2.27 (3H, s, CH3),  7.35 
(1H, d, J=8.0 Hz, Ar-H), 7.45-7.48 (4H, m, Ar-H), 7.51 (1H, t, J=8.6 Hz, Ar-H), 7.76-7.82 (2H, m, Ar-H & 
C=CH), 7.90-7.92 (2H, m, Ar-H), 7.96 (1H, d, J=16.1 Hz, C=CH), 8.20 (2H, d, J=8.0 Hz, Ar-H), 8.28 (2H, d, 
J=9.8 Hz, Ar-H). δC (125 MHz, DMSO-d6) 20.7 (CH3), 121.9 (Ar-C), 122.2 (C=C), 124.2 (Ar-C), 126.5 (Ar-C), 
128.6 (Ar-C), 130.4 (Ar-C), 130.7 (Ar-C), 131.8 (Ar-C), 134.6 (Ar-C), 135.3 (Ar-C), 135.5 (Ar-C), 144.2 (C=C), 
150.5 (Ar-C), 153.8 (Ar-C), 162.2 (C=O ester), 169.2 (C=O ester), 188.1 (C=O). 
 
(E)-4-(3-(3-methoxyphenyl)acryloyl)phenyl 2-acetoxybenzoate (2b): Compound 2b was obtained as 
yellowish solid. Yield: 0.13 g (30%), m.p.: 194-195 °C, (Found: C, 72.24; H, 5.00. C25H20O6 Requires C, 72.11; 
H, 4.84%); vmax (KBr/cm-1) 2840 (OCH3), 1767 (C=O ester), 1666 (C=O), 1601 (Ar-C), 1053 (C=CH). δH (500 
MHz, DMSO-d6) 2.26 (3H, s, CH3),  3.83 (3H, s, OCH3), 7.03 (1H, d, J=10.7 Hz, Ar-H), 7.34 (1H, d, J=8.4 Hz, 
Ar-H), 7.38 (1H, d, J=8.4 Hz, Ar-H), 7.45-7.53 (5H, m, Ar-H), 7.74 (1H, d, J=15.3 Hz, C=CH), 7.78 (1H, t, 
J=8.5 Hz, Ar-H), 7.97 (1H, d, J=16.1 Hz, C=CH), 8.20 (1H, d, J=7.6 Hz, Ar-H), 8.29 (2H, d, J=8.4 Hz, Ar-H). 
δC (125 MHz, DMSO-d6) 21.3 (CH3), 55.8 (OCH3), 114.0 (Ar-C), 117.3 (C=C), 122.3 (Ar-C), 122.5 (Ar-C), 
122.7 (Ar-C), 122.8 (Ar-C), 124.8 (Ar-C), 127.1 (Ar-C), 130.5 (Ar-C), 131.0 (Ar-C), 132.4 (Ar-C), 135.9 (Ar-C), 
136.0 (Ar-C), 136.6 (Ar-C), 144.8 (C=C), 151.1 (Ar-C), 154.4 (Ar-C), 160.2 (Ar-C), 162.8 (C=O ester), 169.8 
(C=O ester), 188.7 (C=O). 
 
(E)-4-(3-(4-methoxyphenyl)acryloyl)phenyl 2-acetoxybenzoate (2c): Compound 2c was obtained as 
yellowish solid. Yield: 0.19 g (45%), m.p.: 126-128 °C, (Found: C, 72.83; H, 5.01. C25H20O6 Requires C, 72.11; 
H, 4.84%); vmax (KBr/cm-1) 2844 (OCH3), 1769 (C=O ester), 1660 (C=O), 1598 (Ar-C), 1031 (C=CH). δH (500 
MHz, DMSO-d6) 2.27 (3H, s, CH3),  3.82 (3H, s, OCH3), 7.02 (2H, d, J=8.4 Hz, Ar-H), 7.34 (1H, d, J=8.4 Hz, 
Ar-H), 7.43 (2H, d, J=8.4 Hz, Ar-H), 7.50 (1H, t, J=7.7 Hz, Ar-H), 7.74-7.88 (5H, m, Ar-H & C=CH), 8.20 
(1H, d, J=6.2 Hz, Ar-H), 8.26 (2H, d, J=8.4 Hz, Ar-H). δC (125 MHz, DMSO-d6) 21.3 (CH3), 55.9 (OCH3), 
115.0 (Ar-C), 119.9 (C=C), 122.5 (Ar-C), 122.7 (Ar-C), 124.8 (Ar-C), 127.1 (Ar-C), 127.8 (Ar-C), 130.8 (Ar-C), 
131.4 (Ar-C), 132.4 (Ar-C), 135.9 (Ar-C), 136.3 (Ar-C), 144.8 (C=C), 151.1 (Ar-C), 154.2 (Ar-C), 162.0 (Ar-C), 
162.8 (C=O ester), 169.8 (C=O ester), 188.5 (C=O). 
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(E)-4-(3-(2,5-dimethoxyphenyl)acryloyl)phenyl 2-acetoxybenzoate (2d): Compound 2d was obtained as 
yellow solid. Yield: 0.09 g (20%), m.p.: 121-122 °C, (Found: C, 69.27; H, 5.09. C26H22O7 Requires C, 69.95; H, 
4.97%); vmax (KBr/cm-1) 2920 (OCH3), 1741 (C=O ester), 1691 (C=O), 1598 (Ar-C), 1011 (C=CH). δH (500 
MHz, DMSO-d6) 2.26 (3H, s, CH3),  3.80 (3H, s, OCH3), 3.85 (3H, s, OCH3), 7.06 (2H, d, Ar-H), 7.35 (1H, d, 
J=6.9 Hz, Ar-H), 7.43 (2H, d, J=8.5 Hz, Ar-H), 7.51 (1H, t, J=7.6 Hz, Ar-H), 7.58 (1H, s, Ar-H), 7.79 (1H, t, 
J=6.2 Hz, Ar-H), 7.92 (1H, d, J=16.1 Hz, C=CH), 8.05 (1H, d, J=15.3 Hz, C=CH), 8.20 (1H, d, J=6.1 Hz, Ar-
H), 8.26 (2H, d, J=8.5 Hz, Ar-H). δC (125 MHz, DMSO-d6) 21.3 (CH3), 56.2 (OCH3), 56.7 (OCH3), 113.1 (Ar-
C), 113.6 (Ar-C), 118.9 (Ar-C), 122.4 (Ar-C), 122.5 (Ar-C), 122.8 (Ar-C), 123.9 (Ar-C), 124.8 (Ar-C), 127.1 
(C=C), 130.9 (Ar-C), 132.4 (Ar-C), 135.9 (Ar-C), 136.2 (Ar-C), 139.0 (C=C), 151.0 (Ar-C), 153.3 (Ar-C), 153.8 
(Ar-C), 154.3 (Ar-C), 162.8 (C=O ester), 169.8 (C=O ester), 188.7 (C=O). 
(E)-4-(3-(3,5-dimethoxyphenyl)acryloyl)phenyl 2-acetoxybenzoate (2e): Compound 2e was obtained as 
yellowish solid. Yield: 0.36 g (40%), m.p.: 124-125 °C, (Found: C, 69.47; H, 4.87. C26H22O7 Requires C, 69.95; 
H, 4.97%); vmax (KBr/cm-1) 2945 (OCH3), 1767 (C=O ester), 1664 (C=O), 1605 (Ar-C), 1049 (C=CH). δH (500 
MHz, DMSO-d6) 2.26 (3H, s, CH3),  3.81 (6H, s, OCH3), 6.60 (1H, s, Ar-H), 7.09 (2H, s, Ar-H), 7.34 (1H, d, 
J=9.2 Hz, Ar-H), 7.44 (2H, d, J=8.6 Hz, Ar-H), 7.50 (1H, t, J=8.0 Hz, Ar-H), 7.68 (1H, d, J=15.5 Hz, C=CH), 
7.78 (1H, t, J=9.2 Hz, Ar-H), 7.95 (1H, d, J=16.1 Hz, C=CH), 8.19 (1H, d, J=10.9 Hz, Ar-H), 8.28 (2H, d, 
J=10.9 Hz, Ar-H). δC (125 MHz, DMSO-d6) 21.3 (CH3), 56.0 (OCH3), 103.5 (Ar-C), 107.3 (Ar-C), 122.5 (Ar-
C), 122.8 (Ar-C), 123.0 (Ar-C), 124.8 (Ar-C), 127.1 (C=C), 131.0 (Ar-C), 132.4 (Ar-C), 135.9 (Ar-C), 136.0 (Ar-
C), 137.1 (Ar-C), 144.9 (C=C), 151.0 (Ar-C), 154.4 (Ar-C), 161.3 (Ar-C), 162.8 (C=O ester), 169.8 (C=O ester), 
188.7 (C=O). 
(E)-4-(3-(4-bromophenyl)acryloyl)phenyl 2-acetoxybenzoate (2f): Compound 2f was obtained as white 
solid. Yield: 0.12 g (26%), m.p.: 251-252 °C, (Found: C, 61.36; H, 3.94. C24H17BrO6 Requires C, 61.95; H, 
3.68%); vmax (KBr/cm-1) 1745 (C=O ester), 1658 (C=O), 1603 (Ar-C), 1047 (C=CH). δH (500 MHz, DMSO-d6) 
2.26 (3H, s, CH3),  7.35 (1H, d, J=8.6 Hz, Ar-H), 7.45 (2H, d, J=8.6 Hz, Ar-H), 7.51 (1H, t, J=7.5 Hz, Ar-H), 
7.67 (2H, d, J=8.6 Hz, Ar-H), 7.73 (1H, d, J=16.0 Hz, C=CH), 7.79 (1H, t, J=7.4 Hz, Ar-H), 7.88 (2H, d, J=8.6 
Hz, Ar-H), 8.01 (1H, d, J=15.5 Hz, C=CH), 8.20 (1H, d, J=8.6 Hz, Ar-H), 8.28 (2H, d, J=8.6 Hz, Ar-H). δC 
(125 MHz, DMSO-d6) 20.7 (CH3), 121.9 (Ar-C), 122.2 (C=C), 122.7 (Ar-C), 124.0 (Ar-C), 124.2 (Ar-C), 126.5 
(Ar-C), 130.4 (Ar-C), 130.8 (Ar-C), 131.9 (Ar-C), 133.9 (Ar-C), 135.3 (Ar-C), 135.4 (Ar-C), 142.8 (C=C), 150.5 
(Ar-C), 153.9 (Ar-C), 162.2 (C=O), 169.2 (C=O ester), 188.0 (C=O). 
 
(E)-4-(3-(4-chlorophenyl)acryloyl)phenyl 2-acetoxybenzoate (2g): Compound 2g was obtained as white 
solid. Yield: 0.22 g (26%), m.p.: 228-230 °C, (Found: C, 68.28; H, 3.69. C25H20O6 Requires C, 68.50; H, 4.07%); 
vmax (KBr/cm-1) 1746 (C=O ester), 1675 (C=O), 1600 (Ar-C), 1038 (C=CH). δH (500 MHz, DMSO-d6) 2.26 
(3H, s, CH3),  7.34 (1H, d, J=8.4 Hz, Ar-H), 7.44 (2H, d, J=8.4 Hz, Ar-H), 7.52-7.54 (3H, m, Ar-H), 7.74 (1H, 
d, J=16.1 Hz, C=CH), 7.79 (1H, t, J=7.7 Hz, Ar-H), 7.93 (2H, d, J=8.4 Hz, Ar-H), 7.97 (1H, d, J=15.3 Hz, 
C=CH), 8.19 (1H, d, J=8.5 Hz, Ar-H), 8.27 (2H, d, J=8.4 Hz, Ar-H). δC (125 MHz, DMSO-d6) 21.3 (CH3), 
122.4 (Ar-C), 122.8 (C=C), 123.2 (Ar-C), 124.8 (Ar-C), 127.1 (Ar-C), 129.5 (Ar-C), 131.0 (Ar-C), 131.2 (Ar-C), 
132.4 (Ar-C), 134.1 (Ar-C), 135.7 (Ar-C), 135.9 (Ar-C), 143.3 (C=C), 151.0 (Ar-C), 154.4 (Ar-C), 162.8 (C=O 
ester), 169.8 (C=O ester), 188.6 (C=O). 
Antibacterial Assay 
 
The antibacterial activities of the synthesized compounds were evaluated against E. coli ATCC 25922 and S. 
aureus S48/81 using disc diffusion method. E. coli and S. aureus were used as inoculum where it was cultured in 
Mueller-Hinton Broth (MHB) and incubated at 37 °C with permanent shaking at 180 rpm for 18 h. The bacterial 
suspension prepared was inoculated onto the entire surface of a Mueller-Hinton Agar (MHA) plate with a sterile 
cotton-tipped swab to form an even lawn. Steriled filter paper disc impregnated with 10 μL of the compound 
in DMSO was placed on the surface of MHA plate using a sterile pair of forceps. The plates were then incubated 
at 37 °C for 24 h. Ampicillin was used as a positive control, DMSO as a negative control and aspirin as a 
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reference. The zones of inhibition were measured in millimeter (mm) to estimate the potency of the test 
compounds (Sie et al., 2018). 
 
Antioxidant Assay 
 
The free radical scavenging activities of the synthesized compounds were determined using stable free radical 
2,2-diphenyl-1-picrylhydrazyl (DPPH). DPPH solution in methanol was prepared with resulting concentration 
of 0.1 mM. Increasing concentrations of tested compounds and aspirin (6.25, 12.50, 50.00, 100.00 and 200.00 
ppm) were prepared using serial dilution in methanol. The tested compound solution (1 mL) was mixed with 4 
mL of DPPH solution and 1 mL of methanol was mixed with 4 mL of DPPH solution as blank. The mixtures 
were kept from light for 30 min and the absorbance of tested solutions was recorded on Optima SP-300 
spectrophotometer at 517 nm. Ascorbic acid was used as standard reference. The IC50 values for all compounds 
were determined by plotting the scavenging activity versus concentration graph (Murti et al., 2013). 
 
 
RESULTS AND DISCUSSION 
 
Chemistry 
Hydroxylated chalcones 1a-g were synthesized in base-catalyzed reaction via Claisen-Schmidt condensation of 
4-hydroxyacetophenone and benzaldehyde derivatives to form yellow solid (24-95%) (Fig. 1) (Ngaini et al., 
2012b). The low yield obtained could be due to formation of Cannizzaro side reaction or ketone auto 
condensation (Ngaini et al., 2012b). 
 
 
 
Fig. 1. Synthesis of hydroxylated chalcones 1a-g 
 
The FTIR spectra of 1a-g showed broad absorption peaks at 3423-3095 cm-1 attributed to –OH groups. The 
presence of methoxy group in the chalcones was indicated by peaks at 2957-2828 cm-1. The frequency at 1653-
1634 cm-1 was corresponded to C=O, while the frequency at 1608-1537 cm-1 were attributed to aromatic groups. 
The v(C=CHalkene) were observed at higher frequency at 1036-974 cm-1 resulting from the effects of conjugation 
with C=O in the molecular structure (Williams & Fleming, 1995).  
 
The 1H NMR spectra indicated significant resonance for methoxy group which observed at 3.80-3.88 ppm as a 
singlet. The aromatic groups were represented by a multiplet in the range of 6.56-8.21 ppm. The formation of 
chalcones were confirmed by resonances at 7.59-7.94 ppm for C=CH with two doublets (Lahsasni et al., 2014). 
Broad peaks at 10.41-10.52 ppm were assigned for hydroxyl group where the signals were at lower field due to 
several factors such as the effects of hydrogen bond, temperature and solvent (Williams & Fleming, 1995). For 
13C NMR, the presence of methoxy groups were confirmed by peaks at 55.5-56.7 ppm, while resonances in the 
range of 98.8-163.4 ppm were attributed to the aromatic groups.  The formation of chalcones was also supported 
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by the peaks at 106.8-143.2 ppm which corresponded to vinylic carbons. The presence of carbonyl group was 
observed at 187.0-187.9 ppm. 
 
Only 1d was successfully produced single crystal for analysis. X-ray crystallography study confirmed the 
formation of 1d with the hydroxyl group at para position in ring A and 2,5-OCH3 group at ring B (Fig. 2). 
 
 
Fig. 2. X-ray crystallography of 1d 
 
Compounds 1a-g were then incorporated onto aspirin by esterification reaction to form aspirin-chalcone 
derivatives 2a-g (Fig. 3). 
 
 
Fig. 3. Proposed synthesis of aspirin-chalcone derivatives 2a-g 
 
Compounds 2a-g were synthesized by reacting hydroxylated chalcones 1a-g with acetylsalicyloyl chloride from 
the reaction of aspirin with oxalyl chloride in the presence of DMF as initiator with yield range 13-20% (Fig. 
4) (Ngaini et al., 2012a). The low yield obtained is due to the presence of electron withdrawing group such as 
bromine and chlorine which decreased the nucleophilic properties of chalcones during reaction (Belharouak & 
Pol, 2012). 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Synthesis of 2a-g utilizing Et3N 
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Higher yield was obtained using dicyclohexylcarbodiimide (DCC) as a stronger coupling agent (Lele et al., 1999) 
and dimethylaminopyridine (DMAP) as catalyst (Tsvetkova et al., 2006) with 20-67% (Fig. 5).  
 
 
 
 
 
 
 
 
Fig. 5. Synthesis of 2a-g utilizing DCC/DMAP 
 
The FTIR spectra supported the formation of aspirin-chalcone derivatives 2a-g by disappearance of broad peak 
attributed to the hydroxyl group in hydroxylated chalcones 1a-g. The appearance of sharp peaks at 1769-1734 
cm-1 was corresponded to C=O ester groups (Motan & Pui, 2014). Peaks at 1605-1600 cm-1 were attributed to 
aromatic groups, whereas the C=C in the chalcone moiety were represented by absorption bands at 1056-1038 
cm-1 (Williams & Fleming, 1995). 
 
The 1H NMR spectra for 2a-g showed –CH3 of aspirin at 2.26-2.27 ppm, while singlets at 3.81-3.82 ppm 
attributed to methoxy group. Multiplet resonances at 6.60-8.28 ppm were corresponded to aromatic groups, 
whereas the C=CH group were represented by peaks at 7.68-8.01 ppm. In 13C NMR spectra, the resonances at 
20.7-21.3 and 55.9-56.0 ppm were assigned for methyl and methoxy groups, respectively. The peaks in the range 
of 103.5-162.8 ppm were attributed to aromatic carbons, whereas the peaks for C=C were observed at 119.9-
148.8 ppm. The presence of two ester groups confirmed by the two peaks corresponded to C=O(ester) at 162.2 
and 169.8 ppm. The carbonyl groups in the chalcone moieties were represented by peaks at 188.1-188.7 ppm. 
 
Antibacterial Activities 
 
The inhibition of E. coli and S. aureus were measured via diameter of inhibition zone for 1a-g and 2a-g in 
comparison to the inhibition zone of ampicillin as shown in Table 1. 
 
Table 1. Inhibition zones of aspirin, ampicillin, 1a-g and 2a-g 
 
Compounds 
Zone of Inhibition (mm) 
E. coli S. aureus 
1a 8.0 - 
1b - - 
1c - - 
1d - - 
1e - - 
1f - - 
1g - - 
2a - - 
2b - - 
2c - - 
2d - - 
2e - - 
2f - - 
2g - - 
Aspirin - - 
DMSO  - - 
Ampicillin  16.0 11.0 
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Note: (-) = No activity   
 
The results showed that only 1a exhibited moderate inhibition towards growth of E. coli and no inhibition against 
S. aureus. The difference in cell membrane component of S. aureus with thicker cell wall could be the cause of 
ineffectiveness in cell membrane penetration compared to E. coli (Lopez-Romero et al., 2015), while 1b-g 
showed no inhibition against both E. coli and S. aureus. The presence of methoxy, bromine and chlorine 
substituents contributed to bulky structure and caused difficult penetration into the cell membrane of bacteria 
(Ngaini & Ho 2017). No inhibition by 2a-g could be due to the additional bulky structures in the compounds 
which hindered the penetration of tested compounds into the cell wall of bacteria. 
 
Antioxidant Activity 
 
The scavenging activities of all the compounds are depicted in Fig. 6 and Fig. 7. Compounds 2e-f were not 
tested due to poor solubility in methanol. 
 
Fig. 6. Free radical scavenging activity of 1a-g 
 
 
 
Fig. 7. Free radical scavenging activity of 2a-g 
 
The graph showed that all tested compounds are very weak free radical scavenger with IC50 of more than 200 
ppm compared to ascorbic acid, IC50 = 12.2 ppm. The addition of aspirin onto chalcones did not enhance the 
antioxidant activity. Poor performance of 1a-g as antioxidant could be due to low phenolic pharmacophore 
presence in the molecules (Jin et al., 2012). Compound 1a showed slight activity compared to 1b-g due to smaller 
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molecular size, while 2a-g have larger molecular structure which unable to combine with DPPH radical caused 
by the steric hindrance (Weng & Huang, 2014). The incorporation of chalcones onto aspirin resulted in bulky 
molecular structures with no biological properties. 
 
 
CONCLUSION 
 
A series of aspirin chalcone derivatives 2a-g were successfully synthesized by incorporation of aspirin and 
hydroxylated chalcones 1a-g via esterification. All synthesized compounds displayed weak antibacterial activities 
against E. coli and S. aureus, and poor scavenging activity on DPPH. The incorporation of chalcones onto aspirin 
resulted in bulky compounds which prevent interaction between receptors, thus reduced the biological activities. 
 
 
ABBREVIATIONS 
 
CHNS: Carbon, Hydrogen, Nitrogen & Sulfur; DCC: N,N-dicyclohexylcarbodiimide; DCM: Dichloromethane; 
DMAP: N,N-dimethyl-4-aminopyridine; DMF: Dimethylformamide; DMSO: Dimethylsulfoxide; DPPH: 2,2-
diphenyl-1-picrylhydrazyl; FTIR: Fourier Transform Infrared; HCl: Hydrochloric acid; IC50: Half-maximal 
inhibitory concentration; KOH: potassium hydroxide; MgSO4: Magnesium sulphate; MHA: Mueller-Hinton Agar; 
MHB: Mueller-Hinton Broth; NMR: Nuclear Magnetic Resonance. 
 
 
ACKNOWLEDGMENTS 
 
The authors acknowledge Universiti Sultan Zainal Abidin for grant support through UniSZA/2017/DPU/02. 
We also acknowledge Universiti Malaysia Sarawak Malaysia for research grant FRGS/ST02(01)/1115/2014(01) 
and Universiti Sains Malaysia for financing this project through 1001/PFIZIK/811238. 
 
 
REFERENCES 
 
Al-Rawi, M. S., Hassan, H. A., Hassan, D. F., & Majeed, I. Y. (2018). New series of substituted heterocyclics 
derived from α, β–unsaturated ketone and their cytotoxic activity tumor cell lines. Oriental Journal of 
Chemistry, 34(6), 2826-2831. 
 
Belharouak, I., & Pol, V. G. (2012). Advances in inorganic phosphate materials: Ceramic transactions. United States of 
America: John Wiley & Sons. 
 
Belsare, D.P., Pal, S.C., Kazi, A.A., Kankate, R.S., & Vanjari, S.S. (2010). Evaluation of antioxidant activity of 
chalcones and flavonoids. International Journal of ChemTech Research, 2(2), 1080-1089. 
 
Gulkok, Y., Bicer, T., Onurdag, F.K., Ozgen, S., Sahin, M.F., & Dogruer, D.S. (2012). Synthesis of some new 
thiourea derivatives and evaluation of their antimicrobial activities. Turkish Journal of Chemistry, 36, 279-
291. 
 
Hasan, S. A., Elias, A. N., & Farhan, M. S. (2015). Synthesis, characterization and antimicrobial evaluation of a 
series of chalcone derivatives. Der Pharma Chemica, 7(2), 39-42. 
 
Ho, B. K., Ngaini, Z., Matthew Neilsen, P., Hwang, S. S., Entigu Linton, R., Kong, E. L., & Lee, B. K. (2017). 
Synthesis and anticancer activities of 4-[(halophenyl) diazenyl] phenol and 4-[(halophenyl) diazenyl] 
phenyl aspirinate derivatives against nasopharyngeal cancer cell lines. Journal of Chemistry, 2017, 1-7. 
 
30 
 
Huang, L., Wong, C. C., Mackenzie, G. G., Sun, Y., Cheng, K. W., Vrankova, K., Alston, N., Ouyang, N., & 
Rigas, B. (2014). Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: An effect 
mediated by EGFR inhibition, p53 acetylation and oxidative stress. BMC Cancer, 14(141), 1-14. 
 
Jin, L., Zhang, Y., Yan, L., Guo, Y., & Niu, L. (2012). Phenolic compounds and antioxidant  activity of bulb 
extracts of six Lilium species native to China. Molecules, 17, 9361-9378. 
 
Kumbhar, D. D., Waghamare, B. Y., Pathade, G. R., & Pardeshi, S. K. (2014). Synthesis and  evaluation of 
chalcones as an antibacterial and antifungal agents. Der Pharmacia Lettre, 6(1), 224-229. 
 
Lahsasni, S. A., Korni, F. H. A., & Aljaber, N. A. (2014). Synthesis, characterization and evaluation of 
antioxidant activities of some novel chalcones analogues. Chemistry Central Journal, 8(32), 1-10. 
 
Lele, B. S., Gore, M. A., & Kulkarni, M. G. (1999). Direct esterification of poly(ethylene glycol) with amino acid 
hydrochlorides. Synthetic Communications, 29(10), 1727-1739. 
 
Lopez-Romero, J. C., Gonzalez-Rios, H., Borges, A., & Simoes, M. (2015). Antibacterial effects and mode of 
action of selected essential oils components against Escherichia coli and Staphylococcus aureus. Evidence-Based 
Complementary and Alternative Medicine, 2015, DOI: 10.1155/2015/795435 
 
Mohana, K.N., & Kumar, C.B.P. (2013). Synthesis and antioxidant activity of 2-amino-5-methylthiazol 
derivatives containing 1,3,4-oxadiazole-2-thiol moiety. ISRN Organic Chemistry, 2013, 1-8. 
 
Motan, G., & Pui, A. (2014). Studies of different types of aspirin by spectrophotometric methods. Acta Chemica 
Iasi, 22(2), 155-164. 
 
Murti, Y., Goswami, A., & Mishra, P. (2013). Synthesis and antioxidant activity of some chalcones and 
flavonoids. International Journal of PharmTech Research, 5(2), 811-818.Ngaini, Z., & Ho, B. K. (2017). 
Synthesis and antibacterial activity of azo and aspirin-azo derivatives. Malaysian Journal of Analytical 
Sciences, 21(5), 1183-1194. 
 
Ngaini, Z., Arif, M. A. M., Hussain, H., Er, S. M., Tang, D., & Kamaluddin, D. H. A. (2012a). Synthesis and 
antibacterial activity of acetoxybenzoyl thioureas with aryl and amino acid side chains. Phosphorus, Sulfur, 
and Silicon and the Related Elements, 187(1), 1-7. 
 
Ngaini, Z., Haris-Fadzillah, S. M., & Hussain, H. (2012b). Synthesis and antimicrobial studies of hydroxylated 
chalcone derivatives with variable chain length. Natural Product Research, 26, 892-902. 
 
Ngaini, Z., Hui, D. H. A., Hussain, H., Zulkiplee, W. S. H. W., Tay, M. G., Sahari, N., & Nordin, N. A. (2013). 
Synthesis and antibacterial study of aspirin-chalcone derivatives. Borneo Journal of Resource Science and 
Technology, 3(1), 52-57. 
 
Nordin, N. A., Lawai, V., Ngaini, Z., Abd Halim, A. N., Hwang, S. S., Linton, R. E., Lee, B. K., & Neilsen, P. 
M. (2018). In vitro cytotoxicity evaluation of thiourea derivatives bearing Salix sp. constituent against 
HK-1 cell lines. Natural Product Research, DOI: 10.1080/14786419.2018.1517120. 
 
Panche, A. N., Diwan, A. D., & Chandra, S. R. (2016). Flavonoids: An overview. Journal of Nutritional Science, 5, 
e47, DOI: 10.1017/jns.2016.41. 
 
Richard-Kortum, R. (2010). Biomedical engineering for global health. United States of America: Cambridge University 
Press. 
 
31 
 
Rubin, E., & Reisner, H.M. (2014). Essentials of Rubin’s pathology (6th ed.). United States of America: Lippincott 
Williams & Wilkins. 
 
Sie, C. Z. W., Ngaini, Z., Suhaili, N., & Madiahlagan, E. (2018). Synthesis of kojic ester derivatives as potential 
antibacterial agent. Journal of Chemistry, 2018, DOI: 10.1155/2018/1245712. 
 
Singhal, M., Paul, A., Singh, H.P., Dubey, S.K., & Songara, R.K. (2011). Synthesis and evaluation of antioxidant 
activity of semicarbazone derivatives. International Journal of Pharmaceutical Sciences and Drug Research, 3(2), 
150-154. 
 
Tsvetkova, B., Tencheva, J., & Peikov, P. (2006). Esterification of 7-theophyllineacetic acid  with diethylene 
glycol monomethyl ether. Acta Pharmaceutica, 56, 251-257. 
 
Vane, J. R., & Botting, R. M. (2003). The mechanism of action of aspirin. Thrombosis Research, 110, 255-258. 
 
Weng, X. C., & Huang, Y. (2014). Relationship structure-antioxidant activity of hindered phenolic compounds. 
Grasas Y Aceites, 65(4), 1-8. 
 
Williams, D. H., & Fleming, I. (1995). Spectroscopic methods in organic chemistry (5th ed.).  England: McGraw-Hill 
Publishing Company. 
 
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017). Chalcone: A privileged structure in 
medicinal chemistry. Chemical Reviews, 117(12), 7762-7810. 
 
 
How to cite this paper: 
Nordin, N. A., Ibrahim, A. R. & Ngaini, Z. (2020). Biological studies of novel aspirin-chalcone derivatives 
bearing variable substituents. Journal of Agrobiotechnology 11(1), 20-31 
 
